Ribonucleic acid (RNA) is a polymeric molecule that plays a role in the coding, decoding, regulation, and expression of genes. MicroRNAs are non-coding endogenous RNAs responsible for post-transcriptional regulation of gene expressions. A specific family of MicroRNAs are diminished in mesothelioma and lung cancer patients, which has led many researchers to study the potential use of these powerful gene regulators in the battle against cancer. Australian researchers have recently used this method on a cohort of six patients and had a near-complete response in one of the male participants. While results are preliminary, this breakthrough may help pave the way for an eventual treatment for the most devastating types of cancer.
Future trials will reveal the true potential of EnGeneIC’s nanocell delivery system to restore MicroRNAs to pre-cancerous levels in mesothelioma patients.
This most recent study is a collaboration between the Asbestos Disease Research Institute, EnGeneIC Ltd. – a private Sydney-based biotech company – and three area hospitals. Future trials will reveal the true potential of EnGeneIC’s nanocell delivery system to restore MicroRNAs to pre-cancerous levels in mesothelioma patients.
There is currently no cure for mesothelioma, but several treatment options can be utilized to improve comfort and extend life expectancy. Mesothelioma treatments can be very expensive however, a factor that may prompt some to avoid looking into them. If you have been diagnosed with mesothelioma, New York mesothelioma attorney Joseph Williams can help you receive the compensation you need to get treatment and live the most rewarding life possible.
To schedule your free consultation, please contact The Williams Law Firm, P.C. online or by calling 855-955-6376 today. Based in New York, we serve victims of asbestos exposure throughout the nation.
